News Sentiment

4883 sentiment intelligence

Modalis Therapeutics Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 55 Balanced news tone 6 relevant articles
Exchange JPX Japan
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 33.00 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

85/100 classification confidence.

Company focus 6

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.0% over one week, -2.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Modalis Highlights CRISPR-GNDM Platform as Cornerstone of Rare Disease Growth Strategy

Market Reaction

Balanced read

56/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 85/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive -2.9% over four weeks
Fair value -64.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 5
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 6
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TipRanks 2
CRISPR Medicine News 2
Moomoo 1
Business Wire 1

Event Lens

What the news is about

Classified themes
Market update 6

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-6 of 6